ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction.
ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction.
复制标题
ADAMTS13 可保护急性心肌梗死小鼠模型中的心肌。
DOI:
10.1160/th12-09-0674
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
and Mitsuhiko Sugimoto.
中科院分区:
文献类型:
--
作者:
Masaaki Doi;Hideto Matsui;Yukiji Takeda;Yoshihiko Saito;Maiko Takeda;Yasunori Matsunari;Kenji Nishio;Midori Shima;Fumiaki Banno;Masashi Akiyama;Koichi Kokame;Toshiyuki Miyata;and Mitsuhiko Sugimoto.
The adhesive protein von Willebrand factor (VWF) plays an essential role on haemostasis (1–3). However, excessive functions of VWF could trigger thrombotic complications. To prevent this, the VWF-cleaving protease ADAMTS13 negatively regulates VWF function by reducing the size of VWF multimers, thereby decreasing their thrombogenic potential (1–3). Since the VWF function is dependent on shear stress (1–4), the relevance of ADAMTS13 may be more pronounced in the microcirculation (5), which is characterised by high shear stress created by blood flow. Indeed, functional deficiencies of ADAMTS13 cause thrombotic occlusion of the microvasculature, eg arterial capillaries, resulting in thrombotic thrombocytopenic purpura (3, 6). Previously, we (7) and others (8, 9) reported that ADAMTS13 deficiency aggravates the extent of brain ischaemic stroke in a mouse model of ischaemia/reperfusion injury by middle cerebral arterial occlusion, suggesting that ADAMTS13 is neuroprotective. These studies demonstrated that ADAMTS13 plays a beneficial role in the microcirculation, which is critical for the preservation of organ functions, raising the possibility that ADAMTS13 might also play a role in coronary ischaemic events such as myocardial infarction. We investigated this possibility in an experimental model of acute myocardial infarction in ADAMTS13 gene deleted (Adamts13-/-) mice.Adamts13-/-(KO) mice were generated on C57BL/6 background by our study group, as described (7, 10). All mice were 12–14 weeks of age, healthy, fertile, and had body weights of 25–30 grams. Mouse experiments were done according to protocols approved by the Ethics Review Committee for Animal Experimentation of Nara Medical University. Researchers were blinded to the genotype of each animal until all studies were completed. Experimental acute myocardial infarction (AMI) in mice was induced as previously described (11). Briefly, following anesthesia by diethyl ether inhalation and insertion of a polyethylene tube into trachea, the left anterior descending coronary artery was ligated with a polyamide suture 2 mm from the tip of the left auricle, under thoracotomy with ventilator-assisted respiration. The same procedure without coronary artery ligation was performed in sham operations. In some experiments, recombinant human ADAMTS13 (3 μg/mouse, equivalent to 2,800 U/kg) was injected intravenously in 30 minutes (min) after the operation. This recombinant protein (designated as MDTCS) used was previously described (12). In brief, MDTCS spans from the metalloproteinase (M) domain to spacer (S) domain (amino acid residues 75–685); it possesses VWF-cleaving activity equivalent to whole ADAMTS13 molecule,